Iowa manufacturer, Brazilian firm team up to deliver CBD products
Industrial Hemp NewsInternational NewsMarijuana Laws, Regulations, & Politics April 15, 2020 MJ Shareholders 0
An Iowa ingredients manufacturer has partnered with Brazilian medical cannabis company to launch several hemp-derived medical cannabis products under the brand name CBD CALM in Brazil.
Kemin Industries of Des Moines will act as the lead consultant for medical marijuana producer MedPharm Iowa, struck a deal in March with Brazilian distributor CBD Vida to deliver cannabinoid-containing products at pharmaceutical standards in Brazil, according to a Tuesday statement from Kemin Industries.
The products are due to be manufactured in Colorado and Michigan, the statement added. Terms of the partnership were not disclosed.
Brazil recently changed its regulations on cannabis derivatives to allow patients with a prescription to buy products containing cannabidiol directly from pharmacies. Under the regulations, which took effect March 10, the bulk import of CBD and THC products is allowed by companies that have been granted a Sanitary Authorization by the Brazilian Health Regulatory Agency (Anvisa).
According to the Kemin Industries statement, the two parties “are partnering to meet all documentation and technical requirements.”
Subscribe to our Newsletter
.LV_validation_message{ font-weight:bold; margin: 0 0 0 5px; } .LV_valid{ color:#00CC00; display:none; } .LV_invalid{ color:#CC0000; font-size:10px; } .LV_valid_field, input.LV_valid_field:hover, input.LV_valid_field:active, textarea.LV_valid_field:hover, textarea.LV_valid_field:active { outline: 1px solid #00CC00; } .LV_invalid_field, input.LV_invalid_field:hover, input.LV_invalid_field:active, textarea.LV_invalid_field:hover, textarea.LV_invalid_field:active { outline: 1px solid #CC0000; }
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers
No comments so far.
Be first to leave comment below.